Publications

IMEREM is proud to contribute to publications or even write such publications about studies we are involved in. The following list presents publications with authors from IMEREM's employees.
 

View complete list of publications on PubMed

Published manuscripts since 2005:

  1. Trenkwalder C, Beneš H, Poewe W, Oertel WH, Garcia-Borreguero D, de Weerd AW, Ferini-Strambi L, Montagna P, Odin P, Stiasny-Kolster K, Högl B, Chaudhuri KR, Partinen M, Schollmayer E, Kohnen R, on behalf of the SP790 Study Group. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurology. Published online 31 May 2008. DOI: 10.1016/S1474 4422(08)70112-1
  2. Oertel WH, Beneš H, Garcia-Borreguero D, Geisler P, Högl B, Saletu B, Trenkwalder C, Sommerville KW, Schollmayer E, Kohnen R, Stiasny-Kolster K; On behalf of the Rotigotine SP 709 Study Group. Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 9;2008:228-239.
  3. Hornyak M, Grossmann C, Kohnen R, Schlatterer M, Richter H, Voderholzer U, Riemann D, Berger M. Cognitive behavioral group therapy to improve patients scoping strategies with restless legs syndrome: A proof-of-concept trial. J Neurol Neurosurg Psychiatry. 2008;79:823-825 [Epub ahead of print, Feb 26 2008; DOI:10.1136/jnnp.2007.138867].
  4. Trenkwalder C, Högl B, Beneš H, Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med. 2007 Oct 5 [Epub ahead of print]
  5. Kohnen R, Benes H. Studien mit Psychopharmaka (Studies with psychotropic drugs). In Benkert O, Gründer G, Holsboer F. Handbuch der Psychopharmakologie (handbook of psychopharmacology). Heidelberg: Springer 2007, pp. 459-476.
  6. García-Borreguero D, Allen RP, Beneš H, Earley C, Happe S, Högl B, Kohnen R, Paulus W, Rye D, Winkelmann J. Augmentation as a treatment complication of restless legs syndrome: Concept and management. Mov Disord. 2007; 22 (Suppl.18):S485-S494.
  7. Beneš H, Walters AS, Allen RP, Hening WA, Kohnen R. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007;22 (Suppl.18):S401-S408.
  8. García-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J; On behalf of the International Restless Legs Syndrome Study Group (IRLSSG). Diagnostic Standards for Dopaminergic Augmentation of Restless Legs Syndrome: Report from a World Association of Sleep Medicine - International Restless Legs Syndrome Study Group Consensus Conference at the Max Planck Institute. Sleep Med. 2007;8:520-530.
  9. García-Borreguero D, Kohnen R, Högl B, Ferini-Strambi L, Hadjigeorgiou GM, Hornyak M, de Weerd AW, Happe S, Stiasny-Kolster K, Gschliesser V, Egatz R, Cabrero B, Frauscher B, Trenkwalder C, Hening WA, Allen RP. Validation of the Augmentation Severity Rating Scale (ASRS): A multicentric, prospective study with levodopa on restless legs syndrome. Sleep Med. 2007;8:455-463.
  10. Tadic A, Rujescu D, Muller MJ, Kohnen R, Stassen HH, Dahmen N, Szegedi A. A monoamine oxidase B gene variant and short-term antidepressant treatment response.Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1370-1377. Epub 2007 Jun 7.
  11. Kohnen R, Allen RP, Beneš H, Garcia-Borreguero D, Hening WA, Stiasny-Kolster K, Zucconi M. Assessment of restless legs syndrome-Methodological approaches for use in practice and clinical trials. Mov Disord. 2007;22 (Suppl.18):S485-S494.
  12. Trenkwalder C, Kohnen R, Allen RP, Beneš H, Ferini-Strambi L, Garcia-Borreguero D, Hadjigeorgiou GM, Happe S, Högl B, Hornyak M, Klein C, Nass A, Montagna P, Oertel WH, O’Keeffe S, Paulus W, Poewe W, Provini F, Pramstaller PP, Sieminski M, Sonka K, Stiasny-Kolster K, de Weerd A, Wetter T, Winkelmann J, Zucconi M. Clinical Investigations of Medicinal Products in the Treatment of Restless Legs Syndrome (RLS). Recommendations of the European RLS Study Group (EURLSSG). Movement Disorders, 2007;22 (Suppl.18), S495-S504.
  13. Trenkwalder C, Beneš H, Grote L, Happe S, Hogl B, Mathis J, Saletu-Zyhlarz GM, Kohnen R. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial. Mov Disord. 2007; 22:696-703.
  14. Tadic A, Müller MJ, Rujescu D, Kohnen R, Stassen HH, Dahmen N, Szegedi A. The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. Am J Med Genet B Neuropsychiatr Genet. 2007;144(3):325-31.
  15. Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M. Comparison of Hypericum Extract WS(R) 5570 and Paroxetine in Ongoing Treatment after Recovery from an Episode of Moderate to Severe Depression: Results from a Randomized Multicenter Study. Pharmacopsychiatry. 2006;39:213-219
  16. Deinzer A, Babel H, Veelken R, Kohnen R, Schmieder RE. Shared decision-making in hypertension: results of implementation in Germany. [Article in German]. Deutsche Medizinische Wochenschrift 2006;131 2592-2596.
  17. Kohnen R. Book review: "Restless Legs Syndrome - The restless legs" [original title in German: "Restless Legs Syndrom - Die unruhigen Beine"]. Psychopharmakotherapie 2006;13:248.
  18. Behrens-Baumann W, Niederdellmann C, Jehkul A, Kohnen R. Bibrocathol eye ointment is efficacious in blepharitis: Results from a randomized, double-blind, controlled clinical trial [Article in German: Bibrocathol - Augensalbe ist wirksam bei Blepharitis]. Opthalmologe 2006;103:960-965.
  19. Jünger M, Klyscz, T, Kohnen R. TLQ-CVI - Tuebingen Questionnaire to measure quality of life in patients with chronic-veneous insufficiency (CVI). In Kupfer J, Schmidt S, Augustin M (Eds). Psychodiagnostic procedures for dermatology. pp.188-191. Goettingen: Hogrefe 2006 (article in German).
  20. Oertel WH, Beneš H, Bodenschatz R, Peglau I, Warmuth R, Happe S, Geisler P, Cassel W, Leroux M, Kohnen R, Stiasny-Kolster K. Efficacy of cabergoline in restless legs syndrome. A placebo-controlled study with polysomnography (CATOR). Neurology. 2006; 26:67:1040-1046
  21. Joos S, Wildau N, Kohnen R, Szecsenyi J, Schuppan D, Willich SN, Hahn EG, Brinkhaus B. Acupuncture and moxibustion in the treatment of ulcerative colitis: A randomized controlled study. Scand J Gastroenterol. 2006;41:1056-1063.
  22. Stiasny-Kolster K, Kohnen R, Carsten Moller J, Trenkwalder C, Oertel WH. Validation of the "L-DOPA test" for diagnosis of restless legs syndrome. Mov Disord. 2006 21(9):1333-1339.
  23. Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder. J Clin Psychopharmacol. 2006;26:75-78.
  24. Henkel V, Mergl R, Allgaier AK, Kohnen R, Moller HJ, Hegerl U. Treatment of depression with atypical features: A meta-analytic approach. Psychiatry Res. 2006;141:89-101.
  25. Beneš H, Deissler A, Rodenbeck A, Engfer A, Kohnen R. Lisuride treatment of Restless Legs Syndrome: first studies with monotherapy in de novo patients and in combination with levodopa in advanced disease. J Neural Transm. 2006;113:87-92.
  26. Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stutzer H, Kohnen R, Willich SN, Lehmacher W, Hahn EG. Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial. Scand J Gastroenterol. 2005;40:936-943.
  27. Brinkhaus B, Joos S, Lindner M, Kohnen R, Witt C, Willich SN, Hahn EG. Integration of complementary and alternative medicine into German medical school curricula -- contradictions between the opinions of decision makers and the status quo. Komplementarmed Klass Naturheilkd. 2005;12:139-143. Epub 2005 Jun 23.
  28. Wehmeier PM, Kluge M, Maras A, Riemann D, Berger M, Kohnen R, Dittmann RW, Gattaz WF. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. Pharmacopsychiatry 2005;38:13-16.
  29. Szegedi A, Kohnen R, Dienel A, Kieser M. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 2005;330:503-506.
  30. Szegedi A, Rujescu D, Tadic A, Muller MJ, Kohnen R, Stassen HH, Dahmen N. The catechol-O-methyltransferase Val(108/158)Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics J. 2005;5:49-53.